| Authors: |
Lee LA; GlaxoSmithKline (GSK), Collegeville, PA, USA., Bailes Z; GSK, Stockley Park West, Uxbridge, Middlesex, UK., Barnes N; GSK, Brentford, Middlesex, UK; Barts and the London School of Medicine and Dentistry, London, UK., Boulet LP; Laval University, Quebec, QC, Canada., Edwards D; GSK, Stockley Park West, Uxbridge, Middlesex, UK., Fowler A; GSK, Stockley Park West, Uxbridge, Middlesex, UK., Hanania NA; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA., Kerstjens HAM; University of Groningen and University Medical Center Groningen, and Groningen Research Institute for Asthma and COPD, Groningen, Netherlands., Kerwin E; Crisor, Clinical Research Institute, Medford, OR, USA., Nathan R; Asthma & Allergy Associates, PC and Research Center, Colorado Springs, CO, USA., Oppenheimer J; Rutgers New Jersey Medical School, Newark, NJ, USA., Papi A; University of Ferrara, Ferrara, Italy., Pascoe S; GlaxoSmithKline (GSK), Collegeville, PA, USA., Brusselle G; Ghent University Hospital, Ghent, Belgium., Peachey G; GSK, Stockley Park West, Uxbridge, Middlesex, UK., Sule N; GlaxoSmithKline (GSK), Collegeville, PA, USA., Tabberer M; GSK, Stockley Park West, Uxbridge, Middlesex, UK., Pavord ID; Nuffield Department of Medicine and Oxford Respiratory NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. Electronic address: ian.pavord@ndm.ox.ac.uk. |
